Newsletter
Newsletter
Review finds improvement in mild depression in association with testosterone replacement therapy
August 21, 2018
A systematic review published on July 14, 2018 in European Urology Focus found a significant association between the use of testosterone replacement therapy (TRT) and a reduction in symptoms of mild depression.
For their review, Mihai Dorin Vartolomei and colleagues at the Medical University of Vienna selected 15 randomized, placebo-controlled trials that included a total of 1,586 adult men with late-onset testosterone deficiency who were treated with TRT. Treatment duration ranged from six weeks to six months.
Testosterone replacement therapy was associated with a reduction in depressive symptoms among men with clinical mild depression. The therapy was also associated with decreased depressive symptoms in men without pretreatment depression. Treatment with the hormone was not found to be associated with improvement among men with major depressive disorder; however, the authors note that in the current studies, men with major depressive disorder received only six weeks of TRT, which is unlikely to be sufficient to improve symptoms.
"Testosterone replacement therapy should thus be considered after taking into account all the risks, benefits, and alternatives in patients with dysthymia and mild depression as part of a shared decision-making process together with the patient," the authors conclude. "The optimal length and type of TRT and the synergistic effect with standard antidepressive strategies need to be further studied, taking into account long-term benefits, risks, and adverse events."
Supplement Guide
What's Hot
Health Concern
Latest Products
 |
|
|||||||||||||||||
|
||||||||||||||||||
Life Extension Clinical Research Update
Spotlight on Women's Health — August
|
Meet Sophia, the Humanoid Robot from Hanson Robotics Limited. She will be attending (and performing!) at RAADfest 2018 in San Diego, California, September 20-23. Life Extension® is proud to be an ally in the quest of supporting age reversal technologies and advances. One of Sophia's purposes, as you will hear her say in this video, is to help process and decode information faster than humans can. Sophia was created using cutting-edge robotics and artificial intelligence technologies developed by Dr. David Hanson, Dr. Ben Goertzel, and their friends at Hanson Robotics in Hong Kong. Sophia is an evolving genius machine. Her incredible human likeness, expressiveness, and remarkable story as an awakening robot over time makes her a fascinating front-page technology story. Dr. Hanson is the founder of Hanson Robotics and a modern-day renaissance man who has built a worldwide reputation for creating robots that look and act amazingly human. After working at Disney as an "imagineer," Dr. Hanson aspired to create genius machines that will surpass human intelligence. He believes that three distinctively human traits must be integrated into the artificial intelligence of these genius machines: creativity, empathy, and compassion. As an extension of human intelligence, Hanson Robotics' genius machines can evolve to solve world problems too complex for humans to solve themselves. Sophia personifies this bold and responsible goal. RAADfest is the largest event in the world in which practical and advanced methods to reverse aging are presented for all interest levels, from beginner to expert. RAADfest is organized by the nonprofit Coalition for Radical Life Extension. Learn more about RAADfest and register at www.raadfest.com Use this Life Extension customer discount code to receive $50 off the price of registration: LEF |
Lab
Testing
How Life Extension lab testing works